D Wave Quantum Stock Price, News & Analysis

D-Wave Quantum (NYSE: QBTS) CEO Dr. Alan Baratz appeared on Fox Business' The Claman Countdown to discuss the company's recent achievements in quantum computing. The highlight was D-Wave's quantum supremacy demonstration, where their Advantage2 quantum computer outperformed a leading supercomputer in complex materials simulation.

Dr. Baratz emphasized that this breakthrough has attracted attention from supercomputer communities and national laboratories worldwide. He also disclosed that their quantum systems are priced between $20-$40 million, with long sales cycles. The company positions its annealing quantum computing technology as key to accelerating commercial adoption, particularly for optimization problems in enterprise applications.

D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software, and services, has announced its management's participation in several upcoming investor conferences throughout May and June 2025. The schedule includes:

• Needham Technology, Media & Consumer Virtual Conference (May 9 & 12)
• J.P. Morgan Global Technology, Media and Communications Conference in Boston (May 13, 8:50 a.m. ET)
• J.P. Morgan Virtual Quantum Conference (May 20)
• B. Riley Institutional Investor Conference in Los Angeles (May 21)
• Stifel 2025 Boston Cross Sector Conference (June 3-4)
• ROTH London Conference (June 24-26)

Tradr ETFs has announced the launch of two new single stock leveraged ETFs: APPX and QBTX. These innovative funds are designed to deliver 200% of the daily performance of AppLovin Corp. (APP) and D-Wave Quantum Systems (QBTS) respectively.

The ETFs represent the first-ever leveraged products tied to these underlying stocks, allowing traders to capitalize on daily stock price movements without using margin accounts. These additions expand Tradr's lineup to nine leveraged ETFs, following their 2022 pioneering launches of single-stock ETFs for Tesla and Nvidia.

The funds target sophisticated investors and professional traders, offering exposure to advertising technology and quantum computing sectors through accessible brokerage accounts, eliminating the need for margin trading or complex options strategies.

D-Wave Quantum (NYSE: QBTS) has scheduled the release of its first quarter fiscal year 2025 financial results on Thursday, May 8, 2025, before market open. The company will host a conference call at 8:00 a.m. Eastern Time on the same day to discuss financial results and business outlook.

The conference call will feature CEO Dr. Alan Baratz and CFO John Markovich. Investors can access the call through domestic (1-877-407-0784) or international (1-201-689-8560) dial-in numbers. An on-demand webcast will be available on D-Wave's Investor Relations website following the call.

D-Wave Quantum (NYSE: QBTS) and Davidson Technologies have completed the physical assembly of Alabama's first on-site Advantage2™ annealing quantum computer at Davidson's Huntsville headquarters. The system is currently undergoing final calibration and readiness testing.

This milestone positions Alabama as a key contributor to U.S. quantum infrastructure, with the system being housed in a secure facility designed for sensitive quantum computing applications. The installation follows a multi-year agreement between the companies, focusing on developing quantum optimization applications for national defense.

Davidson plans to utilize the system for various defense applications, including multi-domain operational optimization, space asset management, and autonomous system coordination. The installation will be celebrated with a VIP ribbon-cutting event on April 23, attended by state and federal dignitaries.

D-Wave Quantum (NYSE: QBTS) and Japan Tobacco's pharmaceutical division have successfully completed a groundbreaking proof-of-concept project combining quantum computing with AI for drug discovery. The project demonstrated that Large Language Models (LLMs) enhanced with D-Wave's quantum-hybrid workflow outperformed classical computing methods in generating novel drug-like molecular structures.

Key findings show that the quantum-hybrid AI system produced more valid molecules with higher drug-likeness compared to traditional approaches. The collaboration utilized D-Wave's annealing quantum computing technology within JT's AI framework to train transformer architecture models, similar to ChatGPT, for exploring chemical space.

The successful proof-of-concept validates quantum computing's potential to enhance AI capabilities while offering more energy-efficient solutions. Japan Tobacco plans to further advance this Quantum AI-driven drug discovery technology for molecular design.

D-Wave Quantum (NYSE: QBTS) announced initiatives to boost adoption of its commercial quantum optimization technology at its Qubits 2025 conference. The company unveiled updates to its hybrid quantum solvers, including support for continuous variables with linear interactions in its nonlinear solver, expanding its capabilities for budget allocation and resource distribution applications.

The company highlighted new use cases including offer allocation, portfolio optimization, and maintenance repair operations (MRO) optimization. Notable customer implementations include NTT DOCOMO's successful deployment, which reduced base station congestion by 15% during peak times, and Ford Otosan's production implementation for vehicle manufacturing sequence optimization.

D-Wave is experiencing increased adoption across end-users, independent software vendors, system integrators, and resellers, with organizations like Davidson Technologies, SAS, Staque, and BBVA exploring quantum solutions for complex optimization challenges.